Summary
The Alternate Site Cardiac Resynchronization study [ALSYNC; NCT01277783] investigated the safety and efficacy of left ventricular endocardial (LVE) pacing using a novel atrial transseptal system for lead delivery. This article discusses the use a lead delivery system with a single pectoral incision for LVE pacing and whether it is both safe and feasible.
- Arrhythmias
- Cardiology Clinical Trials
- Interventional Techniques & Devices
- Cardiology & Cardiovascular Medicine
- © 2014 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.